Current status of sentinel lymph-node biopsy in patients with breast cancer

@article{Cheng2010CurrentSO,
  title={Current status of sentinel lymph-node biopsy in patients with breast cancer},
  author={Gang Cheng and Stephanie Kurita and Drew A. Torigian and Abass Alavi},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2010},
  volume={38},
  pages={562-575}
}
Axillary node status is the most important prognostic indicator for patients with invasive breast cancer. Sentinel lymph-node biopsy (SLNB) is widely accepted and the preferred procedure for identifying lymph-node metastasis. SLNB allows focused excision and pathological examination of the most likely axillary lymph nodes to receive tumor metastases while avoiding morbidities associated with complete axillary nodal dissection. Since its introduction in the early 1990s, the process of SLNB has… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Sentinel Node Mapping for Breast Cancer: Current Situation

VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread--results of a large prospective trial.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2013
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 134 REFERENCES

Similar Papers

Loading similar papers…